Twin Tree Management, LP Horizon Therapeutics Public LTD CO Transaction History

Twin Tree Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $11.4 Million - $20.8 Million	183,077 New	183,077 $20.8 Million
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $1.53 Million - $2.25 Million	-19,298 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $1.67 Million - $2.12 Million	19,298 New	19,298 $2.03 Million
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $10.3 Million - $12.5 Million	-104,485 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $2.89 Million - $3.46 Million	31,391 Added 42.95%	104,485 $11.4 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $685,952 - $762,947	7,954 Added 12.21%	73,094 $6.85 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $1.54 Million - $2.05 Million	21,492 Added 49.24%	65,140 $6 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $308,334 - $388,362	4,602 Added 11.79%	43,648 $3.19 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $5.37 Million - $7.77 Million	-97,166 Reduced 71.33%	39,046 $3.03 Million
Q2 2020 Aug 12, 2020	BUY	$30.2 - $56.98 $4.06 Million - $7.65 Million	134,336 Added 7160.77%	136,212 $7.57 Million
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $46,656 - $72,338	1,876 New	1,876 $56,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.